Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study

Autologous stem cell transplantation (ASCT) and chimeric antigen receptor T-cells (CAR-T) have been used as consolidation therapies for patients with refractory/relapsed B cell non-Hodgkin’s lymphoma (R/R B-NHL) in remission after second-line chemotherapy or salvage therapy. However, patients with d...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Danyang Li, Rui Liu, Zhonghua Fu, Fan Yang, Lixia Ma, Yuelu Guo, Miaomiao Cao, Yang Lei, Yimeng Dou, Xuenan Zhang, Yan Gao, Bian Wei, Biping Deng, Xiaoyan Ke, Kai Hu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Subjects:	B-NHL CAR-T ASCT combination therapy refractory/relapsed B-cell lymphoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532460/full